# VENLAFAXINE HYDROCHLORIDE
> **ANDA217390** · Abbreviated New Drug Application (Generic) · Sponsor: GRANULES · Approved 2023-05-18
## Drug
- **FDA Application Number:** ANDA217390
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VENLAFAXINE HYDROCHLORIDE
- **Generic name:** VENLAFAXINE HYDROCHLORIDE
- **Active ingredients:** VENLAFAXINE HYDROCHLORIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GRANULES
- **Manufacturer:** Granules Pharmaceuticals Inc.
- **First approval:** 2023-05-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217390)
---
*AI Analytics · CC0 1.0*